Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Provention Bio
Provention Bio
(PRVB)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tzield
Teplizumab
2022-11-17
Type 1 diabetes mellitus
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Teplizumab
diabetes mellitus
,
type 1 diabetes mellitus
Cilmostim
crohn disease
Ademetionine
diabetes mellitus
,
type 1 diabetes mellitus
EDICOTINIB
crohn disease
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use